Influence of admission plasma glucose level on short- and long-term prognosis in patients with ST-segment elevation myocardial infarction
Open Access
- 1 January 2010
- journal article
- Published by National Library of Serbia in Vojnosanitetski Pregled
- Vol. 67 (4) , 291-295
Abstract
Background/Aim. Hyperglicemia is common in patients with ST-elevation myocardial infarction (STEMI) and is associated with high risk of mortality and morbidity. Relationship between admission plasma glucose (APG) levels and mortality in diabetic and nondiabetic patients with STEMI needs further investigation. The aim of this study was to analyse the short- and longterm prognostic significance of APG levels in patients with STEMI with and without diabetes. Methods. This study included 115 patients with STEMI, 86 (74,8%) nondiabetic and 29 (25,2%) dibaetic patients, in which we performed a prospective analysis of the relationship between APG levels and shortand long-term mortality. Results. Comparison of APG levels between nondiabetic (8.32 ± 2.4 mmol/L) and diabetic (10.09 ± 2.5 mmol/L) patients showed statistically significantly higher average APG levels in diabetic patients (p = 0.001). In all patients observed who died either after one month or one year after STEMI, average APG values were significantly higher in comparison with those in survived patients. There was no statistical significance in average APG levels in the diabetic patients with STEMI who died after one month and those who survived (10.09 ± 2.68 vs 10.0 ± 2.51 mmol/L, respectively; p = 0.657), as well as those who died after one year and those who survived (10.1 ± 1.92 vs 10.09 ± 2.8 mmol/L, respectively; p = 0.996). There was, however, statistical significance in average APG levels in the nondiabetic patients with STEMI who died after one month and those who survived (9.97 ± 2.97 vs 7.91 ± 2.08 mmol/L, respectively; p = 0.001), as well as those who died after one year and those who survived (9.17 ± 2.49 vs 7.84 ± 2.24 mmol/L, respectively; p = 0.013). Conclusion. Acute hyperglicemia in the settings of STEMI worsenes the prognosis in patients with and without diabetes. Our study showed that nondiabetic patients with high APG levels are at higher risk of mortality than patients with a known history of diabetes.Keywords
This publication has 24 references indexed in Scilit:
- Admission glycaemia and outcome in patients with acute coronary syndromeDiabetes & Vascular Disease Research, 2007
- Prognostic value of admission glucose and glycosylated haemoglobin levels in acute coronary syndromesQJM: An International Journal of Medicine, 2006
- The association between hyperglycaemia on admission and 180‐day mortality in acute myocardial infarction patients with and without diabetesDiabetic Medicine, 2005
- Dysglycemia in suspected acute coronary syndromesEuropean Journal of Internal Medicine, 2005
- Prognostic value of admission glucose in non-diabetic patients with myocardial infarctionAmerican Heart Journal, 2004
- Admission Blood Glucose Level as Risk Indicator of Death After Myocardial Infarction in Patients With and Without Diabetes MellitusArchives of internal medicine (1960), 2004
- Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE projectEuropean Heart Journal, 2003
- Association between hyperglycemia and the no-reflow phenomenon inpatients with acute myocardial infarctionJACC, 2003
- Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?JACC, 2002
- Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic PatientsStroke, 2001